Search Results - "Chaudhry, Afzal"

Refine Results
  1. 1

    Generating an iPSC Bank for HLA-Matched Tissue Transplantation Based on Known Donor and Recipient HLA Types by Taylor, Craig J., Peacock, Sarah, Chaudhry, Afzal N., Bradley, J. Andrew, Bolton, Eleanor M.

    Published in Cell stem cell (03-08-2012)
    “…The likelihood for immunological rejection of Human Leukocyte Antigens (HLA)-mismatched induced pluripotent stem cells (iPSCs) limits their therapeutic…”
    Get full text
    Journal Article
  2. 2

    Clinical features and radiological findings in large vessel vasculitis: are Takayasu arteritis and giant cell arteritis 2 different diseases or a single entity? by Furuta, Shunsuke, Cousins, Claire, Chaudhry, Afzal, Jayne, David

    Published in Journal of rheumatology (01-02-2015)
    “…Takayasu arteritis (TAK) and giant cell arteritis (GCA) are 2 major variants of large vessel vasculitis (LVV). The frequent involvement of large vessels in GCA…”
    Get full text
    Journal Article
  3. 3

    The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease by Marco, Helena, Smith, Rona M, Jones, Rachel B, Guerry, Mary-Jane, Catapano, Fausta, Burns, Stella, Chaudhry, Afzal N, Smith, Kenneth G C, Jayne, David R W

    Published in BMC musculoskeletal disorders (25-05-2014)
    “…Rituximab is a B cell depleting anti-CD20 monoclonal antibody. CD20 is not expressed on mature plasma cells and accordingly rituximab does not have immediate…”
    Get full text
    Journal Article
  4. 4

    Comparison of the Phenotype and Outcome of Granulomatosis with Polyangiitis Between UK and Japanese Cohorts by Furuta, Shunsuke, Chaudhry, Afzal N, Arimura, Yoshihiro, Dobashi, Hiroaki, Fujimoto, Shouichi, Homma, Sakae, Rasmussen, Niels, Jayne, David R

    Published in Journal of rheumatology (01-02-2017)
    “…There are differences in the frequencies of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis subgroups between different geographic regions,…”
    Get full text
    Journal Article
  5. 5

    ACE inhibitor and angiotensin receptor-II antagonist prescribing and hospital admissions with acute kidney injury: a longitudinal ecological study by Tomlinson, Laurie A, Abel, Gary A, Chaudhry, Afzal N, Tomson, Charles R, Wilkinson, Ian B, Roland, Martin O, Payne, Rupert A

    Published in PloS one (06-11-2013)
    “…ACE Inhibitors (ACE-I) and Angiotensin-Receptor Antagonists (ARAs) are commonly prescribed but can cause acute kidney injury (AKI) during intercurrent illness…”
    Get full text
    Journal Article
  6. 6

    Alemtuzumab for refractory primary systemic vasculitis-a randomised controlled dose ranging clinical trial of efficacy and safety (ALEVIATE) by Gopaluni, Seerapani, Smith, Rona, Goymer, Donna, Cahill, Hugh, Broadhurst, Elizabeth, Wallin, Elizabeth, McClure, Mark, Chaudhry, Afzal, Jayne, David

    Published in Arthritis research & therapy (01-04-2022)
    “…Primary systemic vasculitis (PSV) is a heterogeneous group of autoimmune conditions. There is an unmet need for alternative therapies that lead to sustained…”
    Get full text
    Journal Article
  7. 7

    Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis by Smith, Rona M., Jones, Rachel B., Guerry, Mary-Jane, Laurino, Simona, Catapano, Fausta, Chaudhry, Afzal, Smith, Kenneth G. C., Jayne, David R. W.

    Published in Arthritis & rheumatology (Hoboken, N.J.) (01-11-2012)
    “…Objective Rituximab is effective induction therapy in refractory or relapsing antineutrophil cytoplasmic antibody–associated vasculitis (AAV). However, further…”
    Get full text
    Journal Article
  8. 8

    B-Cell–Depleting Induction Therapy and Acute Cellular Rejection by Clatworthy, Menna R, Watson, Christopher J.E, Plotnek, Gemma, Bardsley, Vicky, Chaudhry, Afzal N, Bradley, J. Andrew, Smith, Kenneth G.C

    Published in The New England journal of medicine (18-06-2009)
    “…To the Editor: B-cell depletion is an effective treatment for a number of autoimmune diseases in which B cells were not previously considered to be important,…”
    Get full text
    Journal Article
  9. 9

    A CD8 + T cell transcription signature predicts prognosis in autoimmune disease by Lyons, Paul A, Smith, Kenneth G C, McKinney, Eoin F, Carr, Edward J, Hollis, Jane L, Jayne, David R W, Willcocks, Lisa C, Koukoulaki, Maria, Brazma, Alvis, Jovanovic, Vojislav, Kemeny, D Michael, Pollard, Andrew J, MacAry, Paul A, Chaudhry, Afzal N

    Published in Nature medicine (01-05-2010)
    “…Autoimmune diseases are common and debilitating, but their severe manifestations could be reduced if biomarkers were available to allow individual tailoring of…”
    Get full text
    Journal Article
  10. 10

    Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis by Alberici, Federico, Smith, Rona M, Jones, Rachel B, Roberts, Darren M, Willcocks, Lisa C, Chaudhry, Afzal, Smith, Kenneth G C, Jayne, David R W

    Published in Rheumatology (Oxford, England) (01-07-2015)
    “…ANCA-associated vasculitis (AAV) is characterized by a chronic relapsing course. Rituximab (RTX) is an effective maintenance treatment; however, the long-term…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Alemtuzumab as Remission Induction Therapy in Behçet Disease: A 20-year Experience by Mohammad, Aladdin J, Smith, Rona M, Chow, Yok W, Chaudhry, Afzal N, Jayne, David R W

    Published in Journal of rheumatology (01-10-2015)
    “…To study the efficacy and safety of anti-CD52 antibody (alemtuzumab) in the treatment of refractory and relapsing Behçet disease (BD). Thirty-two patients (22…”
    Get full text
    Journal Article
  13. 13

    Proof-of-concept solution to create an interoperable timeline of healthcare data by Trivedi, Sapna, Hall, Stephen, Inglis, Fiona, Chaudhry, Afzal

    Published in BMJ health & care informatics (01-11-2023)
    “…ObjectivesTo overcome the barriers of interoperability by sharing simulated patient data from different electronic health records systems and presenting them…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Predicting HLA Class II Alloantigen Immunogenicity From the Number and Physiochemical Properties of Amino Acid Polymorphisms by KOSMOLIAPTSIS, Vasilis, SHARPLES, Linda D, CHAUDHRY, Afzal N, HALSALL, David J, BRADLEY, J. Andrew, TAYLOR, Craig J

    Published in Transplantation (27-01-2011)
    “…We have shown previously that human leukocyte antigen (HLA) class I immunogenicity can be predicted by the number, position, and physiochemical differences of…”
    Get full text
    Journal Article
  17. 17

    Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification by Lyons, Paul A, Koukoulaki, Maria, Hatton, Alexander, Doggett, Karen, Woffendin, Hayley B, Chaudhry, Afzal N, Smith, Kenneth G C

    Published in BMC genomics (05-03-2007)
    “…For expression profiling to have a practical impact in the management of immune-related disease it is essential that it can be applied to peripheral blood…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Using machine learning to model older adult inpatient trajectories from electronic health records data by Herrero-Zazo, Maria, Fitzgerald, Tomas, Taylor, Vince, Street, Helen, Chaudhry, Afzal N., Bradley, John R., Birney, Ewan, Keevil, Victoria L.

    Published in iScience (20-01-2023)
    “…Electronic Health Records (EHR) data can provide novel insights into inpatient trajectories. Blood tests and vital signs from de-identified patients’ hospital…”
    Get full text
    Journal Article